Trial design and patient population
diabetic nephropathy
DIABETIC NEPHROPATHY
The study was conducted as a non-blinded randomized clinical trial in the Abu Ali Sina solid organ transplantation hospital which affiliated to Shiraz University of Medical Sciences, Shiraz, Iran from July of 2022 to December of 2022. The simple randomized method was used to randomize the study subjects. The participants included those of 18 years old or above, suffering from diabetic nephropathy who met the SPK criteria of our center [The protocol and patient informed consent form were reviewed and approved by the local Ethics Committee of Shiraz University of Medical Sciences (IR.SUMS.MED.REC.1401.045). The study was registered at the Iranian Registry of Clinical Trials (IRCT 20210625051701N2; 
CONSORT diagram of the enrollment, inclusion and exclusion of patients in the course of study